Namit, Eliezer M.
HRN: 27-56-84 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/15/2025
09/05/2025
IV
2.25g
Q6h
Acute Bacterial Infection, Resistance
Checking Initial Appropriateness
08/26/2025
MUPIROCIN 2%, 15G (TUBE)
08/26/2025
09/01/2025
TOPICAL
Apply Bid
BID
Decubitus Ulcer
Checking Initial Appropriateness
09/04/2025
MUPIROCIN 2%, 15G (TUBE)
09/04/2025
09/11/2025
TOPICAL
2%
BID
Sacral Ulcer
Checking Initial Appropriateness
09/04/2025
MUPIROCIN 2%, 15G (TUBE)
09/04/2025
09/11/2025
TOPICAL
2%
BID
Sacral Ulcer
Checking Initial Appropriateness
09/11/2025
MUPIROCIN 2%, 15G (TUBE)
09/11/2025
09/17/2025
TOPICAL
15g
BID
Sacral Ulcer
Checking Initial Appropriateness